Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis
Clinical trial NCT01480076 · COMPLETED
Trial details
- NCT number
- NCT01480076
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-07-01
- Enrollment
- 901
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.